Literature DB >> 8077516

Antifungal therapy: potential interactions with other classes of drugs.

D R Bickers1.   

Abstract

Combination drug therapy is widely used for the management of many common medical conditions. The concurrent use of more than one drug can significantly alter the therapeutic and side-effect profile of each individual agent. Such drug-drug interactions are generally classified either as pharmacokinetic or pharmacodynamic. Oral agents used for the management of superficial fungal infections can have both types of interactions. This article describes common drug-drug interactions observed with amphotericin B, flucytosine, griseofulvin, ketoconazole, fluconazole, and itraconazole.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077516     DOI: 10.1016/s0190-9622(08)81276-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

Review 1.  Important drug interactions in dermatology.

Authors:  T C Roos; H F Merk
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  Systemic antifungal agents.

Authors:  W Abuhammour; E Habte-Gabr
Journal:  Indian J Pediatr       Date:  2001-07       Impact factor: 1.967

Review 3.  Management of onychomycoses.

Authors:  M Niewerth; H C Korting
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 4.  Treatment and prophylaxis of tinea infections.

Authors:  G E Piérard; J E Arrese; C Piérard-Franchimont
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.